These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1057698)
21. Molecules in the middle molecular weight range. Critical review of methods of separation from fluids of uremic patients. Contreras P; Later R; Navarro J; Touraine JL; Freyria AM; Traeger J Nephron; 1982; 32(3):193-201. PubMed ID: 6759948 [No Abstract] [Full Text] [Related]
22. Blood level of middle molecular substances during uraemia and haemodialysis. Dzúrik R; Bozek P; Reznícek J; Oborníková A Proc Eur Dial Transplant Assoc; 1973; 10(0):263-70. PubMed ID: 4802412 [No Abstract] [Full Text] [Related]
23. [Exchangeable sodium, fluid space and hypertonia in chronic uremia]. Vorburger C; Hodler J; Reubi F Helv Med Acta Suppl; 1969; 49():178. PubMed ID: 5267574 [No Abstract] [Full Text] [Related]
24. An overview of clinical implications of middle molecules and their kinetics in uremia. Funck-Brentano JL; Man NK Artif Organs; 1981; 4 Suppl():125-32. PubMed ID: 7295078 [TBL] [Abstract][Full Text] [Related]
25. Separation and quantification of the "middle molecules" in uremia. Chapman GV; Ward RA; Farrell PC Kidney Int; 1980 Jan; 17(1):82-8. PubMed ID: 7374022 [TBL] [Abstract][Full Text] [Related]
26. What causes toxicity in uraemia? Br Med J; 1977 Jul; 2(6080):143-4. PubMed ID: 871815 [No Abstract] [Full Text] [Related]
27. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates. Montali U; Pilone N; Cioni L; Ronca G Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888 [TBL] [Abstract][Full Text] [Related]
28. [Distribution of low- and medium-molecular-weight substances in biological fluids of healthy children]. Gorbatova LN; Bebiakova NA; Sumarokova AV Fiziol Cheloveka; 2007; 33(1):114-8. PubMed ID: 17361616 [No Abstract] [Full Text] [Related]
29. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia]. Popławski A; Myśliwiec M Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935 [TBL] [Abstract][Full Text] [Related]
35. [Middle molecules--a marker of endogenous intoxication (a review of the literature)]. Parfenkova GA; Cherniad'eva IF; Sitina VK Vrach Delo; 1987 Apr; (4):72-7. PubMed ID: 3303687 [No Abstract] [Full Text] [Related]
36. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney. Smeby LC; Jörstad S; Wideröe TE; Svartaas TM Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075 [TBL] [Abstract][Full Text] [Related]
37. A method for separation of middle molecules by high performance liquid chromatography: application in studies of glucuronyl-o-hydroxyhippurate in normal and uremic subjects. Zimmerman L; Bergström J; Jörnvall H Clin Nephrol; 1986 Feb; 25(2):94-100. PubMed ID: 3698350 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum. Bourgoignie J; Klahr S; Bricker NS J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168 [TBL] [Abstract][Full Text] [Related]